Robert Michael Dudley
Chief Executive Officer at TransCode Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: TransCode Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
TransCode Therapeutics Inc. May 10, 202395.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 28, 2023 | TransCode Therapeutics Inc. | Open-market purchase | +98,000 | $0.51 | $49,980 |
| Jun 21, 2023 | TransCode Therapeutics Inc. | Open-market purchase | +12,000 | $2.65 | $31,800 |
| Jun 20, 2023 | TransCode Therapeutics Inc. | Open-market purchase | +6,607 | $2.55 | $16,848 |
| Jun 9, 2023 | TransCode Therapeutics Inc. | Open-market purchase | +19,000 | $2.76 | $52,440 |
Questions about Robert Michael Dudley
What boards is Robert Michael Dudley on?
Robert Michael Dudley sits on the board of TransCode Therapeutics Inc.
What company is Robert Michael Dudley the CEO of?
Robert Michael Dudley is Chief Executive Officer of TransCode Therapeutics Inc.
How long has Robert Michael Dudley served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.